Shandong Boan Biotechnology Co., Ltd. (HKG:6955)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
4.790
-0.110 (-2.24%)
Jun 18, 2026, 11:29 AM HKT
Market Cap3.05B -41.2%
Revenue (ttm)873.36M +8.1%
Net Income7.95M -90.2%
EPS0.01 -90.9%
Shares Out 622.33M
PE Ratio383.58
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,181,000
Open4.870
Previous Close4.900
Day's Range4.720 - 4.920
52-Week Range4.540 - 19.900
Beta0.02
AnalystsHold
Price Target11.03 (+130.27%)
Earnings DateAug 27, 2026

About HKG:6955

Shandong Boan Biotechnology Co., Ltd., a biopharmaceutical company, develops, manufactures, and markets biologics in Mainland China. The company offers Boyounuo (BA1101), an anti-VEGF humanized monoclonal antibody injection for mCRC, advanced metastatic or recurrent non-small cell lung cancer, recurrent glioblastoma, epithelial ovarian, fallopian tube, primary peritoneal cancer, cervical cancer, and hepatocellular carcinoma indications; Boyoubei (BA6101), a human immunoglobulin G2 monoclonal antibody of the RANK ligand for the treatment of post... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2013
Employees 696
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 6955
Full Company Profile

Financial Performance

In 2025, HKG:6955's revenue was 784.82 million, an increase of 8.06% compared to the previous year's 726.32 million. Earnings were 7.14 million, a decrease of -90.24%.

Financial numbers in CNY Financial Statements